- Home
- NXPL vs SER Comparison
NXPL vs SER Comparison
Compare NXPL & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXPL | SER |
|---|---|---|
| Founded | 1997 | 2017 |
| Country | United States | United States |
| Employees | 130 | 13 |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.8M | 19.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NXPL | SER |
|---|---|---|
| Price | $6.36 | $1.74 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | 24.5K | ★ 83.4K |
| Earning Date | 05-15-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.34 | $1.22 |
| 52 Week High | $8.37 | $7.92 |
Technical Indicators
Market Signals| Indicator | NXPL | SER |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 48.53 |
| Support Level | $0.59 | $1.75 |
| Resistance Level | $7.19 | $1.96 |
| Average True Range (ATR) | 0.90 | 0.15 |
| MACD | -0.17 | 0.00 |
| Stochastic Oscillator | 11.98 | 30.00 |
Price Performance
Historical ComparisonAbout NXPL NextPlat Corp
NextPlat Corp is an e-commerce and healthcare company. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.